CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
Werte in diesem Artikel
CVS Health’s CVS Pharmacy & Consumer Wellness (“PCW”) unit includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. It also provides pharmacy fulfillment services to support the Health Services segment’s specialty and mail order pharmacy offerings. For several quarters, the segment’s main challenge has been the continued pharmacy reimbursement pressure stemming from managed care organizations, pharmacy benefit managers (PBMs) and governmental and other third-party payors working to reduce their prescription drug costs, often by using restrictive networks.Despite this, PCW reported solid results for the second quarter of 2025, with revenues up 12% year over year. Same-store basis increased more than 15%, while same-store prescription volumes jumped nearly 7%. CVS Health attributed the performance to its ability to anticipate market dynamics and act accordingly to lead the industry. It invested in technology and staffing to bolster its operations and service, while also aiming to be the preferred employer in the pharmacy market.The front store business gained momentum as the company expanded its customer base and gained retail share. CVS continues to source and negotiate generic pharmaceutical supply contracts through Red Oak, its joint venture with Cardinal Health, and extend those savings with its payer partners via CVS CostVantage. The new reimbursement model is designed to remove the traditional market reliance on cross-subsidization caused by market basket approaches, offering greater clarity and allowing CVS Pharmacy to set prices and contracts aligned with current market conditions while preparing for future changes.Further, the company is advancing the next stage of pharmacy reimbursement model evolution, shifting its government business to cost-based pricing models for 2026.Updates From CVS’ Pharmacy & Consumer Wellness RivalsElevance Health ELV and the National Association of Community Health Centers (“NACHC”) recently announced the integration of Food as Medicine (FAM) programming with primary care Community Health Centers (“CHCs”). The initiative expands Elevance Health’s existing regional Nourished Well program serving Medicaid individuals by training primary care provider teams within CHCs on the effectiveness of FAM for patients and families. Built on a shared commitment to whole health and community-centered innovation, the step marks an important advancement in addressing food/nutrition insecurity and diet-related chronic conditions through clinical integration.The Kroger Co. KR achieved identical sales without fuel growth of 3.2%, excluding adjustment items, in the first quarter of 2025. This was driven by strong pharmacy, e-commerce, and fresh sales. The quarter also marked the seventh consecutive period where Kroger’s Our Brands outpaced national brands, led by Simple Truth and Private Selection. Notably, Simple Truth will soon introduce 80 new protein products, ranging from bars and powders to shakes, all from a natural and organic brand that customers trust.CVS’ Price Performance, Valuation and EstimatesYear to date, CVS Health shares have risen 59.1% compared with the industry’s modest 0.2% growth. Image Source: Zacks Investment ResearchCVS’ shares are trading at a forward three-year price-to-sales ratio of 0.23, lower than the 0.41 industry average. The stock has a Value Score of A.Image Source: Zacks Investment ResearchThe consensus estimate for the company’s 2025 earnings is showing a bullish trend. Image Source: Zacks Investment ResearchCVS currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Kroger Co. (KR): Free Stock Analysis Report CVS Health Corporation (CVS): Free Stock Analysis Report Elevance Health, Inc. (ELV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: CVS Health und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf CVS Health
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CVS Health
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu CVS Health Corp
Analysen zu CVS Health Corp
Datum | Rating | Analyst | |
---|---|---|---|
05.06.2019 | CVS Health Buy | Standpoint Research | |
15.04.2019 | CVS Health Perform | Oppenheimer & Co. Inc. | |
12.04.2019 | CVS Health Market Perform | BMO Capital Markets | |
18.12.2018 | CVS Health Overweight | Barclays Capital | |
26.10.2018 | CVS Health Peer Perform | Wolfe Research |
Datum | Rating | Analyst | |
---|---|---|---|
05.06.2019 | CVS Health Buy | Standpoint Research | |
12.04.2019 | CVS Health Market Perform | BMO Capital Markets | |
18.12.2018 | CVS Health Overweight | Barclays Capital | |
30.01.2018 | CVS Health Strong Buy | Needham & Company, LLC | |
02.01.2018 | CVS Health Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
15.04.2019 | CVS Health Perform | Oppenheimer & Co. Inc. | |
26.10.2018 | CVS Health Peer Perform | Wolfe Research | |
28.06.2017 | CVS Health Hold | Needham & Company, LLC | |
02.02.2017 | CVS Health Neutral | Robert W. Baird & Co. Incorporated | |
22.06.2016 | CVS Health Hold | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
25.07.2005 | Update Longs Drug Stores Corp.: Underperform | Bear Stearns |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für CVS Health Corp nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen